Nu Skin vs USANA

This page compares Nu Skin and USANA Health Sciences Inc., examining their business models, financial performance, and market context in a clear, neutral way for readers. Educational content, not financial advice.

About The Companies

Nu Skin (NUS)

Nu Skin Enterprises (NUS) is a US-listed personal care and wellness company that distributes skincare, nutritional supplements and beauty devices through a direct-selling network. Key considerations for investors include the company’s reliance on independent distributors, exposure to consumer trends and international markets, and sensitivity to regulatory and reputational issues common to multi-level marketing businesses. With a modest market capitalisation (about $537m), the stock can be more volatile than larger consumer staples names. Potential attractions are recurring product demand and premium devices that can support margins, while risks include competitive pressure, changing consumer preferences, currency moves and regulatory scrutiny in several jurisdictions. This summary is educational only, not personalised investment advice — values can rise and fall and past performance is not a reliable guide. Investors should assess risk tolerance, diversification and seek independent financial advice if needed.

USANA (USNA)

USANA Health Sciences (USNA) is a US-based maker of nutritional supplements, personal care products and weight-management items, sold primarily through a direct-selling (independent distributor) model. Investors should note its reliance on distributor recruitment and repeat consumer sales, with meaningful geographic exposure to Asia Pacific markets which have been key revenue drivers. With a market capitalisation of about $384.26m, USNA sits in the small-cap range and can show higher volatility than larger peers. Key attractions include brand recognition in targeted markets, recurring consumable sales and potential leverage from international expansion. Key risks are regulatory scrutiny of direct-selling practices, competition from other supplement brands and sensitivity to consumer spending, foreign exchange and input-cost pressures. Earnings can be lumpy and growth often depends on distributor trends rather than purely retail metrics. This is general educational information, not personal financial advice — suitability depends on an investor’s goals, time horizon and risk tolerance.

Comparison Snapshot

Key Financial Metrics

NUS

Metric

USNA

$517.24M

Market Cap

$373.48M

N/A

Potential Profit

42.65%

N/A

Analyst Rating

N/A

Which Baskets Do They Appear In?

Clean Living

Tap into the growing movement toward natural products and wellness. This carefully selected group of stocks represents companies dedicated to providing pure, organic, and non-toxic alternatives across food, personal care, and household goods.

Published: June 17, 2025

Explore Basket

Which Baskets Do They Appear In?

Clean Living

Published: June 17, 2025

Explore Basket

Investment Analysis

Nu Skin

NUS

Pros

Reported a solid Q3 2025 revenue of $364.2 million with adjusted EPS of $0.34, exceeding EPS expectations and maintaining guidance.
Core business maintains a strong gross margin of 70.5% and has successfully reduced selling expenses to 35.8%, improving operational efficiency.
Strong cash balance of $251.7 million supports liquidity, with growth initiatives underway including a new product preview and India market entry planned.

Considerations

Q3 revenue came in slightly below analyst estimates, indicating potential top-line growth challenges.
The company’s market capitalization has declined significantly over the past decades, reflecting long-term valuation pressures.
Forward price-to-earnings ratio near 9 with a neutral analyst rating suggests limited near-term valuation upside.

USANA

USNA

Pros

USANA Health Sciences operates in the growing health and wellness sector with a strong nutritional supplement portfolio.
Reported revenue growth in recent periods supported by expanding international presence, particularly in Asia.
Maintains a focused direct selling model, which can enhance customer loyalty and reduce reliance on traditional retail channels.

Considerations

Faces regulatory scrutiny risks common in the nutritional supplement industry, which could impact operations and reputation.
Highly competitive market with significant pressure from other established wellness and supplement companies may constrain growth.
Stock valuation appears elevated relative to some peers, potentially reflecting stretched expectations for near-term growth.

Why invest with Nemo?

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Nu Skin vs Village Super Market

Nu Skin vs Village Super Market: a quick compare

Nu Skin vs Oatly

Nu Skin vs Oatly: a comparison of business models

Nu Skin vs Village Farms

Nu Skin vs Village Farms: company comparison

Nu Skin vs USANA

About The Companies

Comparison Snapshot

Which Baskets Do They Appear In?

Clean Living

Which Baskets Do They Appear In?

Clean Living

Investment Analysis

Nu Skin

Pros

Considerations

USANA

Pros

Considerations

Why invest with Nemo?

Zero Commission

Trusted & Regulated

6% Interest on Cash

Discover More Comparisons

Nu Skin vs Village Super Market

Nu Skin vs Oatly

Nu Skin vs Village Farms

Frequently asked questions

What is the basic difference between Nu Skin and USANA in terms of business focus?

How is revenue growth discussed for each company in the context provided?

What does the pricing/valuation information tell us about near-term upside?

How do margins contribute to evaluating profitability for these stocks?

What role does cash position play in assessing these companies?

What external market factors are common to both stocks in this context?

How does international expansion influence the outlook for both companies?

What should a reader consider when comparing quarterly results against longer-term strategy?

What is the importance of guidance and analyst ratings in this comparison?

Why are margins and cash balance discussed together in these profiles?

What regulatory risks might affect both companies in the nutraceutical space?

Educational disclaimer for readers

About The Companies

Comparison Snapshot